This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bingen, E.
Right arrow Articles by Deforche, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bingen, E.
Right arrow Articles by Deforche, D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2000, p. 1453-1457, Vol. 44, No. 6
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Resistance to Macrolides in Streptococcus pyogenes in France in Pediatric Patients

Edouard Bingen,1,* Frederic Fitoussi,1 Catherine Doit,1 Robert Cohen,2 Asha Tanna,3 Robert George,3 Chawki Loukil,1 Naima Brahimi,1 Isabelle Le Thomas,1 and Dominique Deforche1

Service de Microbiologie, Hôpital Robert Debré, 75019 Paris,1 and Service de Microbiologie, Centre Hospitalier de Créteil, 94010 Créteil,2 France, and Central Public Health Laboratory, London, United Kingdom3

Received 2 September 1999/Returned for modification 26 December 1999/Accepted 3 March 2000

A total of 1,500 recent throat isolates of Streptococcus pyogenes collected between 1996 and 1999 from children throughout France were tested for their susceptibility to erythromycin, azithromycin, josamycin, clindamycin, and streptogramin B. The erythromycin-resistant isolates were further studied for their genetic mechanism of resistance, by means of PCR. The clonality of these strains was also investigated by means of serotyping and ribotyping. In all, 6.2% of the strains were erythromycin resistant, and 3.4 and 2.8% expressed the constitutive MLSB and M resistance phenotypes and harbored the ermB and mefA genes, respectively; ermTR was recovered from one isolate which also harbored the ermB gene. Ten serotypes and 8 ribotypes were identified, but we identified 17 strains by combining serotyping with ribotyping. Among the eight ribotypes, the mefA gene was recovered from six clusters, one being predominant, while the ermB gene was recovered from four clusters, of which two were predominant.


* Corresponding author. Mailing address: Service de Microbiologie, Hôpital R. Debré, 48 Bd Sérurier, 75019 Paris, France. Phone: 33 (1) 40 03 23 40. Fax: 33 (1) 40 03 24 50. E-mail: edouard.bingen{at}rdb.ap-hop-paris.fr.


Antimicrobial Agents and Chemotherapy, June 2000, p. 1453-1457, Vol. 44, No. 6
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Richter, S. S., Heilmann, K. P., Dohrn, C. L., Beekmann, S. E., Riahi, F., Garcia-de-Lomas, J., Ferech, M., Goossens, H., Doern, G. V. (2008). Increasing telithromycin resistance among Streptococcus pyogenes in Europe. J Antimicrob Chemother 61: 603-611 [Abstract] [Full Text]  
  • Dogan, B., Schukken, Y. H., Santisteban, C., Boor, K. J. (2005). Distribution of Serotypes and Antimicrobial Resistance Genes among Streptococcus agalactiae Isolates from Bovine and Human Hosts. J. Clin. Microbiol. 43: 5899-5906 [Abstract] [Full Text]  
  • Sangvik, M., Littauer, P., Simonsen, G. S., Sundsfjord, A., Dahl, K. H. (2005). mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway. J Antimicrob Chemother 56: 841-846 [Abstract] [Full Text]  
  • Haller, M., Fluegge, K., Arri, S. J., Adams, B., Berner, R. (2005). Association between Resistance to Erythromycin and the Presence of the Fibronectin Binding Protein F1 Gene, prtF1, in Streptococcus pyogenes Isolates from German Pediatric Patients. Antimicrob. Agents Chemother. 49: 2990-2993 [Abstract] [Full Text]  
  • Klaassen, C. H. W., Mouton, J. W. (2005). Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E). Antimicrob. Agents Chemother. 49: 1271-1278 [Full Text]  
  • Fluegge, K., Supper, S., Siedler, A., Berner, R. (2004). Antibiotic Susceptibility in Neonatal Invasive Isolates of Streptococcus agalactiae in a 2-Year Nationwide Surveillance Study in Germany. Antimicrob. Agents Chemother. 48: 4444-4446 [Abstract] [Full Text]  
  • Bingen, E., Bidet, P., Mihaila-Amrouche, L., Doit, C., Forcet, S., Brahimi, N., Bouvet, A., Cohen, R. (2004). Emergence of Macrolide-Resistant Streptococcus pyogenes Strains in French Children. Antimicrob. Agents Chemother. 48: 3559-3562 [Abstract] [Full Text]  
  • Acikgoz, Z. C., Almayanlar, E., Gamberzade, S., Gocer, S. (2004). Macrolide Resistance Determinants of Invasive and Noninvasive Group B Streptococci in a Turkish Hospital. Antimicrob. Agents Chemother. 48: 1410-1412 [Abstract] [Full Text]  
  • Bingen, E., Doit, C., Bidet, P., Brahimi, N., Deforche, D. (2004). Telithromycin Susceptibility and Genomic Diversity of Macrolide-Resistant Serotype III Group B Streptococci Isolated in Perinatal Infections. Antimicrob. Agents Chemother. 48: 677-680 [Abstract] [Full Text]  
  • Acikgoz, Z. C., Gocer, S., Tuncer, S. (2003). Macrolide resistance determinants of group A streptococci in Ankara, Turkey. J Antimicrob Chemother 52: 110-112 [Abstract] [Full Text]  
  • Poyart, C., Jardy, L., Quesne, G., Berche, P., Trieu-Cuot, P. (2003). Genetic Basis of Antibiotic Resistance in Streptococcus agalactiae Strains Isolated in a French Hospital. Antimicrob. Agents Chemother. 47: 794-797 [Abstract] [Full Text]  
  • Sauermann, R., Gattringer, R., Graninger, W., Buxbaum, A., Georgopoulos, A. (2003). Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics. J Antimicrob Chemother 51: 53-57 [Abstract] [Full Text]  
  • Malbruny, B., Nagai, K., Coquemont, M., Bozdogan, B., Andrasevic, A. T., Hupkova, H., Leclercq, R., Appelbaum, P. C. (2002). Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother 49: 935-939 [Abstract] [Full Text]  
  • Cresti, S., Lattanzi, M., Zanchi, A., Montagnani, F., Pollini, S., Cellesi, C., Rossolini, G. M. (2002). Resistance Determinants and Clonal Diversity in Group A Streptococci Collected during a Period of Increasing Macrolide Resistance. Antimicrob. Agents Chemother. 46: 1816-1822 [Abstract] [Full Text]  
  • Bingen, E., Leclercq, R., Fitoussi, F., Brahimi, N., Malbruny, B., Deforche, D., Cohen, R. (2002). Emergence of Group A Streptococcus Strains with Different Mechanisms of Macrolide Resistance. Antimicrob. Agents Chemother. 46: 1199-1203 [Abstract] [Full Text]  
  • Martin, J. M., Green, M., Barbadora, K. A., Wald, E. R. (2002). Erythromycin-Resistant Group A Streptococci in Schoolchildren in Pittsburgh. NEJM 346: 1200-1206 [Abstract] [Full Text]  
  • Nagai, K., Appelbaum, P. C., Davies, T. A., Kelly, L. M., Hoellman, D. B., Andrasevic, A. T., Drukalska, L., Hryniewicz, W., Jacobs, M. R., Kolman, J., Miciuleviciene, J., Pana, M., Setchanova, L., Thege, M. K., Hupkova, H., Trupl, J., Urbaskova, P. (2002). Susceptibility to Telithromycin in 1,011 Streptococcus pyogenes Isolates from 10 Central and Eastern European Countries. Antimicrob. Agents Chemother. 46: 546-549 [Abstract] [Full Text]  
  • Portier, H., Filipecki, J., Weber, P., Goldfarb, G., Lethuaire, D., Chauvin, J.-P. (2002). Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study. J Antimicrob Chemother 49: 337-344 [Abstract] [Full Text]  
  • Nagai, K., Davies, T. A., Ednie, L. M., Bryskier, A., Palavecino, E., Jacobs, M. R., Appelbaum, P. C. (2001). Activities of a New Fluoroketolide, HMR 3787, and Its (Des)-Fluor Derivative RU 64399 Compared to Those of Telithromycin, Erythromycin A, Azithromycin, Clarithromycin, and Clindamycin against Macrolide-Susceptible or -Resistant Streptococcus pneumoniae and S. pyogenes. Antimicrob. Agents Chemother. 45: 3242-3245 [Abstract] [Full Text]  
  • Farrell, D. J., Morrissey, I., Bakker, S., Felmingham, D. (2001). Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization. J Antimicrob Chemother 48: 541-544 [Abstract] [Full Text]  
  • Fines, M., Gueudin, M., Ramon, A., Leclercq, R. (2001). In vitro selection of resistance to clindamycin related to alterations in the attenuator of the erm(TR) gene of Streptococcus pyogenes UCN1 inducibly resistant to erythromycin. J Antimicrob Chemother 48: 411-416 [Abstract] [Full Text]  
  • Weber, P., Filipecki, J., Bingen, E., Fitoussi, F., Goldfarb, G., Chauvin, J. P., Reitz, C., Portier, H. (2001). Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemother 48: 291-294 [Abstract] [Full Text]  
  • Fitoussi, F., Loukil, C., Gros, I., Clermont, O., Mariani, P., Bonacorsi, S., Le Thomas, I., Deforche, D., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in France. Antimicrob. Agents Chemother. 45: 1889-1891 [Abstract] [Full Text]  
  • Fitoussi, F., Doit, C., Geslin, P., Brahimi, N., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France. Antimicrob. Agents Chemother. 45: 636-638 [Abstract] [Full Text]  
  • Syrogiannopoulos, G. A., Grivea, I. N., Tait-Kamradt, A., Katopodis, G. D., Beratis, N. G., Sutcliffe, J., Appelbaum, P. C., Davies, T. A. (2001). Identification of an erm(A) Erythromycin Resistance Methylase Gene in Streptococcus pneumoniae Isolated in Greece. Antimicrob. Agents Chemother. 45: 342-344 [Abstract] [Full Text]